Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SKP59 is a *pseudogene* corresponding to the functional gene *RN7SK*, which encodes 7SK small nuclear RNA. Pseudogenes are typically non-functional DNA segments that resemble functional genes but have lost their gene expression or coding potential due to mutations or genomic rearrangement. The functional *RN7SK* gene product, 7SK RNA, is a critical regulator of transcriptional elongation in metazoans, mainly by sequestering and inhibiting the positive transcription elongation factor b (P-TEFb). However, *RN7SKP59* itself does not encode a functional RNA molecule and has **no demonstrated biological activity, clinical relevance, or role as a therapeutic target**[1][2][3][4]. Because *RN7SKP59* is a pseudogene, it is **not considered a therapeutic target** and does not participate in canonical molecular Families such as receptors, enzymes, ion channels, or transcription factors. There are **no known drugs, disease associations, or biomarker roles** for this pseudogene, and its presence is primarily of interest for genomic annotation rather than as a molecular target for research or therapy. Key notes: - The **actual therapeutic/research target** associated with transcriptional regulation is *RN7SK*, not *RN7SKP59*. - Because the pseudogene is non-functional, the entry is best marked as *is_incorrect: true* for most research/therapeutic database purposes. If you need detail on *functional* 7SK (RN7SK), that would be a distinct entry with different properties and significant biological interest.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SK small nuclear pseudogene 59 (RN7SKP59).